This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Mark Bittinger: Innovator in Cancer Treatment
Introduction
Mark Bittinger is a notable inventor based in Dover, MA (US). He has made significant contributions to the field of cancer research through his innovative work. His dedication to identifying and treating cancer has led to the development of groundbreaking methods and compositions.
Latest Patents
Mark Bittinger holds a patent for "Compositions and methods for identification, assessment, prevention, and treatment of cancer using NFS1 biomarkers and modulators." This invention focuses on the identification of novel mitochondrial iron-sulfur (Fe–S) cluster biosynthesis pathway biomarkers and modulators. It provides methods for identifying, assessing, preventing, and treating cancer, showcasing his commitment to advancing medical science.
Career Highlights
Bittinger is associated with the Dana-Farber Cancer Institute Inc., where he continues to work on innovative solutions for cancer treatment. His career is marked by a strong focus on research and development in the medical field.
Collaborations
He collaborates with esteemed colleagues such as Jessie M. English and Kwok-kin Wong, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Mark Bittinger's work exemplifies the spirit of innovation in cancer research. His contributions are paving the way for new methods of treatment and assessment, ultimately aiming to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile